Healthcare-associated catheter-related bloodstream infections (HA-BSIs) remain a major cause of morbidity and mortality in the U.S.
Infusion & Vascular Access
Global medical device company CareFusion Corp.
Hospitals may reduce the risk of life-threatening bloodstream infections in newborns with peripherally inserted central venous catheters by replacing the device every 30 days or so, according to a new Johns Hopkins Children’s Center
B. Braun Medical Inc.
FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings
The Food and Drug Administration (FDA) announced today that, in response to a request from the Centers for Disease Control and Prevention (CDC), it has issued an emergency use authorization (EUA) for the investigational antiviral dr
The last decade of evolution in the efforts to reduce healthcare-acquired infections (HAIs) has seen a multitude of new initiatives and requirements that address, among other issues, the elimination of central line-associated bloodstream
How to meet new infection control guidelines from the Joint Commission and those contained in the SHEA/IDSA Compendium will be the focus of a panel discussion at the upcoming annual meeting of the Association for Vascu